Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion type Assertion NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_head.
- NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion wasGeneratedBy ECO_0000203 NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_provenance.
- NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion wasDerivedFrom befree-2016 NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_provenance.
- NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion SIO_000772 19361262 NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_provenance.
- NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion evidence source_evidence_literature NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_provenance.
- NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_assertion description "[Furthermore, in vivo administration of GM-CSF at 60 microg/kg body weight daily for 5 consecutive days beginning immediately after injury decreased infarction volume, altered the expression of several apoptosis-related genes (Bcl-2, Bax, caspase 3, and p53), and improved locomotor behavior in the focal cerebral ischemia model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731926.RA7oZsNTr9n0bSE1ziwMBGS0B24RD3dHu4PkTxwCfNTNE130_provenance.